Ermic-13l is an advanced phytotherapeutic formula developed from rare wild desert plants of the Arabian Peninsula, designed to support patients with liver malignancies, including hepatocellular carcinoma (HCC), as well as pathologies of the biliary tract and gallbladder. This supplement is based on modern research on secondary bioactive metabolites, which exhibit a broad spectrum of biological activities that contribute to hepatoprotection and cellular regeneration.*
Ermic-13l exerts its therapeutic properties through multiple biological pathways:
Phytochemical and pharmacological studies have demonstrated that Ermic-13l possesses a wide range of biological activities:
Ermic-13l is rich in tannins, flavonoids, alkaloids, saponins, phenolic acids, and sterols, among which more than 24 standard bioactive compounds have been identified, including:
These secondary metabolites have been documented for their antiproliferative, hepatoprotective, antioxidant, neuroprotective, and immunomodulatory effects in scientific research.